Clinical Trial Update: Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing atamestane plus toremifene versus letrozole in advanced breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Atamestane (atamestane)
• Letrozole (letrozole)
• Toremifene (toremifene)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Breast Neoplasms, Neoplasms, Hormone-Dependent | Phase 3 | Status: TERMINATED